Schonfeld Strategic Advisors LLC Immuno Gen, Inc. Transaction History

Schonfeld Strategic Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.46 - $29.95 $4.43 Million - $10.7 Million	-355,796 Reduced 90.65%	36,704 $1.09 Million
Q3 2023 Nov 14, 2023	BUY	$14.09 - $19.87 $218,831 - $308,600	15,531 Added 4.12%	392,500 $6.23 Million
Q2 2023 Aug 14, 2023	BUY	$3.75 - $20.05 $1.41 Million - $7.56 Million	376,969 New	376,969 $7.11 Million
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.47 $414,861 - $599,141	92,603 New	92,603 $443,000
Q1 2022 May 16, 2022	SELL	$4.26 - $7.48 $236,004 - $414,392	-55,400 Closed	0 $0

Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $194,275 - $306,750	40,900 Added 282.07%	55,400 $410,000
Q2 2021 Aug 16, 2021	BUY	$5.79 - $8.6 $83,955 - $124,700	14,500 New	14,500 $95,000
Q2 2019 Aug 14, 2019	SELL	$1.8 - $3.3 $39,240 - $71,940	-21,800 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.41 - $5.91 $14,460 - $35,460	6,000 Added 37.97%	21,800 $59,000
Q4 2018 Feb 14, 2019	BUY	$3.94 - $9.7 $62,252 - $153,260	15,800 New	15,800 $76,000
Q1 2018 May 15, 2018	SELL	$6.7 - $12.95 $5.8 Million - $11.2 Million	-865,356 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$5.07 - $7.92 $473,989 - $740,432	-93,489 Reduced 9.75%	865,356 $5.55 Million
Q3 2017 Nov 14, 2017	BUY	$5.4 - $8.47 $5.18 Million - $8.12 Million	958,845	958,845 $7.34 Million

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.